These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 9179071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA, Doorduijn Y, Bulten JH, Verloop J, Massuger LF, Kiemeney BA.
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [Abstract] [Full Text] [Related]

  • 3. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
    Horwitz RI, Viscoli CM, Merino M, Brennan TA, Flannery JT, Robboy SJ.
    J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
    [Abstract] [Full Text] [Related]

  • 4. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL, Cole P, Colton T, Robboy SJ, Scully RE.
    Am J Obstet Gynecol; 1977 May 01; 128(1):43-50. PubMed ID: 851158
    [Abstract] [Full Text] [Related]

  • 5. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States.
    Smith EK, White MC, Weir HK, Peipins LA, Thompson TD.
    Cancer Causes Control; 2012 Jan 01; 23(1):207-11. PubMed ID: 22015647
    [Abstract] [Full Text] [Related]

  • 6. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Huo D, Anderson D, Palmer JR, Herbst AL.
    Gynecol Oncol; 2017 Sep 01; 146(3):566-571. PubMed ID: 28689666
    [Abstract] [Full Text] [Related]

  • 7. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC, Edelman DA.
    Obstet Gynecol; 1978 Apr 01; 51(4):459-63. PubMed ID: 662229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL.
    J Ark Med Soc; 1979 May 01; 75(12):451-2. PubMed ID: 156173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE, Guintoli RL, Sedlacek TV, Rocereto T, Rubin E, Burtnett M, Mikuta JJ.
    Am J Obstet Gynecol; 1979 Aug 15; 134(8):860-5. PubMed ID: 463989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb 15; 22(2):139-43. PubMed ID: 6822019
    [Abstract] [Full Text] [Related]

  • 18. The current status of the DES-exposed population.
    Herbst AL.
    Obstet Gynecol Annu; 1981 Feb 15; 10():267-78. PubMed ID: 7024873
    [Abstract] [Full Text] [Related]

  • 19. High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.
    Kocken M, Baalbergen A, Snijders PJ, Bulten J, Quint WG, Smedts F, Meijer CJ, Helmerhorst TJ.
    Gynecol Oncol; 2011 Aug 15; 122(2):297-302. PubMed ID: 21620450
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.